BECN1 and acute myeloid leukemia: It has been reported that Beclin 1 inhibits apoptotic signaling in AML cells by enhancing Bcl‐xL binding to Beclin 1 and reducing Bad‐Bcl‐xL complex that promotes apoptosis [33].